Your browser doesn't support javascript.
loading
Antibody-drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells.
Abedin, Muhammad Raisul; Powers, Kaitlyne; Aiardo, Rachel; Barua, Dibbya; Barua, Sutapa.
Afiliación
  • Abedin MR; Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, 110 Bertelsmeyer Hall, 1101 N. State Street, Rolla, MO, 65409-1230, USA.
  • Powers K; Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, 110 Bertelsmeyer Hall, 1101 N. State Street, Rolla, MO, 65409-1230, USA.
  • Aiardo R; Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, 110 Bertelsmeyer Hall, 1101 N. State Street, Rolla, MO, 65409-1230, USA.
  • Barua D; Department of Electrical and Computer Engineering, Missouri University of Science and Technology, Rolla, MO, 65409, USA.
  • Barua S; Department of Chemical and Biochemical Engineering, Missouri University of Science and Technology, 110 Bertelsmeyer Hall, 1101 N. State Street, Rolla, MO, 65409-1230, USA. baruas@mst.edu.
Sci Rep ; 11(1): 7347, 2021 04 01.
Article en En | MEDLINE | ID: mdl-33795712

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Paclitaxel / Receptor ErbB-2 / Nanopartículas / Trastuzumab / Anticuerpos Límite: Female / Humans Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Paclitaxel / Receptor ErbB-2 / Nanopartículas / Trastuzumab / Anticuerpos Límite: Female / Humans Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido